"Zanamivir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
| Descriptor ID |
D053243
|
| MeSH Number(s) |
D02.078.370.926 D02.241.081.844.562.668.775 D02.241.511.902.562.668.775 D03.383.663.859 D09.067.687.668.775 D09.811.589.668.775
|
| Concept/Terms |
Zanamivir- Zanamivir
- 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid
- 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid
- 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid
- 4-Guanidino-Neu5Ac2en
- 4 Guanidino Neu5Ac2en
- 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid
- 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid
- 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid
- Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic
|
Below are MeSH descriptors whose meaning is more general than "Zanamivir".
Below are MeSH descriptors whose meaning is more specific than "Zanamivir".
This graph shows the total number of publications written about "Zanamivir" by people in this website by year, and whether "Zanamivir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Zanamivir" by people in Profiles.
-
Intravenous Zanamivir in Hospitalized Patients With Influenza. Pediatrics. 2017 Nov; 140(5).
-
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
-
Recommendations for Prevention and Control of Influenza in Children, 2016-2017. Pediatrics. 2016 10; 138(4).
-
Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J. 2015 Jun; 45(6):1642-52.
-
A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase. Chembiochem. 2012 Oct 15; 13(15):2191-5.
-
Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)? Cell Res. 2009 Oct; 19(10):1221-4.
-
Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J. 2008 Aug; 27(8):738-43.
-
Measures for control of influenza. Pharmacoeconomics. 1999; 16 Suppl 1:41-5.
-
A new antiviral agent for influenza--is there a clinical niche? N Engl J Med. 1997 Sep 25; 337(13):927-8.